Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients

Virchows Archiv

Volumn 446, Issue 3, 2005, Pages 232-238

  Borromeo, Cecilia M ^a   Pottier, Xavier ^a   In't Veld, Peter A ^a   Pipeleers Marichal, Miriam A ^a   Kaufman, Leonard ^a   Pipeleers, Daniel G ^a   Van Schravendijk, Christiaan F ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Human pancreas; Islet amyloid; Islets of Langerhans; Morphometry; Type 2 diabetes

Indexed keywords

AMYLOID; CONGO RED; SYNAPTOPHYSIN;

AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TISSUE SECTION;

AGED; AGED, 80 AND OVER; AMYLOID; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; PANCREATIC POLYPEPTIDE;

EID: 17644392453     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1171-5     Document Type: Article

References (27)

1. Clark A (1992) Islet amyloid: an enigma of type 2 diabetes. Diabetes Metab Rev 8:117-132
2. Clark A, Holman RR, Matthews DR, Hockaday TDR, Turner RC (1984) Non-uniform distribution of islet amyloid in the pancreas of "maturity-onset" diabetic patients. Diabetologia 27:527-528
3. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151-159
4. Clark A, Saad MF, Nezzer T, Uren C, Knowler WC, Bennett PH, Turner RC (1990) Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 33:285-289
5. Furuta K, Yang XL, Chen JS, Hamilton SR, August JT (1991) Differential expression of the lysosome-associated membrane proteins in normal human tissues. Arch Biochem Biophys 365:75-82
6. Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27[Suppl 1]:251-261
7. Jorns A (1994) Immunocytochemical and ultrastructural heterogeneities of normal and glibenclamide stimulated pancreatic beta cells in the rat. Virchows Arch 425:305-313
8. Klöppel G, In't Veld PA (1997) Morphology of the pancreas in normal and diabetic states. In: KGMM Alberti, P Zimmet, RA DeFronzo (eds) International textbook of diabetes mellitus, 2nd edn. John Wiley & Sons, pp 287-313
9. Lazarus SS, Volk BW (1962) The pancreas in human and experimental diabetes. Grune & Stratton, New York
10. Linke RP (2000) Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch 436:439-448
11. Maloy AL, Longnecker DS, Greenberg ER (1981) The relation of islet amyloid to the clinical type of diabetes. Hum Pathol 12:917-922
12. Mathews PM, Guerra CB, Jiang Y, (2002) Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis. J Biol Chem 277:5299-5307
13. Opie E (1901) The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of Langerhans. J Exp Med 5:527-540
14. Pipeleers D (1987) The biosociology of pancreatic beta cells. Diabetologia 30:277-291
15. Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209-227
16. Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M, Bouwens L, Ling Z (2001) Role of pancreatic beta-cells in the process of beta-cell death. Diabetes 50[Suppl 1]:S52-S57
17. Puchtler H, Sweat F (1965) Congo red as a stain for fluorescence microscopy of amyloid. J Histochem Cytochem 13:693-694
18. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S (2002) Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85-96
19. Sempoux C, Guiot Y, Dubois D, Moulin P, Rahier J (2001) Human type 2 diabetes: morphological evidence for abnormal beta-cell function. Diabetes 50[Suppl 1]:S172-S177
20. Stefan Y, Meda P, Neufeld M, Orci L (1987) Stimulation of insulin secretion reveals heterogeneity of pancreatic B cells in vivo. J Clin Invest 80:175-183
21. Van Schravendijk CF, Kiekens R, Pipeleers DG (1992) Pancreatic beta cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267:21344-21348
22. Wang F, Hull RL, Vidal J, Cnop M, Kahn SE (2001) Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50:2514-2520
23. Watanabe T, Yaegashi H, Koizumi M, Toyota T, Takahashi T (1999) Changing distribution of islets in the developing human pancreas: a computer-assisted three-dimensional reconstruction study. Pancreas 18:349-354
24. Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15:417-421
25. Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30:887-892
26. Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE (1986) Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci U S A 83:3500-3504
27. Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC (2003) Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 52:2759-2766